Breast Cancer Related News
Radiotherapy does not improve survival rates for older patients
Adding radiotherapy to the current standard treatment for breast cancer did not improve survival rates for patients aged 65 years or older.
Radiotherapy is a...
Nearly four in ten women missed out on breast cancer screening
New figures reveal that almost four in ten women did not take up the breast cancer screening offered in 2022.
Thousands of women have now...
A new trial on proton beam therapy will be carried out in the UK
A new trial testing the benefits of proton beam therapy for breast cancer patients will go ahead for the first time in the UK.
The...
Radiotherapy treatment can only stop cancer recurrence in the short-term
Radiotherapy treatment for breast cancer only reduces the risk of cancer returning for ten years, having no effect thereafter, according to research from the...
Benign breast disease increases the risk of breast cancer
Women with benign breast disease are twice as likely to be diagnosed with breast cancer, according to research from Hospital del Mar in Barcelona.
The...
Scientists uncover variable voltages in breast cancer cells
New research from Imperial College London found variable voltages in the membranes of breast cancer cells, revealing clues about how they grow and spread.
A...
NHS strike life-saving deal for pembrolizumab
In an exciting announcement, the NHS has revealed it has secured a potentially lifesaving deal for pembrolizumab, a drug tailored to breast cancer.
Pembrolizumab is...
Dense breast tissue can lead to higher risk of cancer
Researchers from Linköping University have found that there are major biological differences between dense breast tissue and non-dense breast tissue, suggesting that dense breasts...
New immunotherapy treatment for breast cancer may possible
Researchers from King’s College London and the Institute of Cancer Research have identified immune cell types that could be used to develop a new...
Queen’s University Belfast awarded funding for breast cancer treatment research
Researchers at Queen’s University Belfast have received funding from Breast Cancer Now to discover new breast cancer treatments.
This new research is inspired by the...
Hormone treatment for breast cancer reduces the risk of recurrence
Researchers conducted a 20-year follow-up on the long-term benefits of hormone treatment for breast cancer.
The Karolinska Institutet in Sweden investigated the long-term benefits of...
Does the NHS Breast Screening Programme cause overdiagnosis?
Evidence from a Queen Mary University of London study has revealed that the benefits of the NHS Breast Screening Programme outweigh the small risk...
Alpelisib becomes 100th fast tracked NHS cancer drug
Alpelisib – a life-extending drug for patients with advanced breast cancer – has become the 100th fast-tracked cancer drug on the NHS and will...
New targeted treatment for early-stage breast cancer available on NHS
Provisional approval by NICE could see a step-change in treatment for early-stage breast cancer following surgery.
The National Institute of Health and Care Excellence (NICE)...
New immunotherapy for a rare form of triple-negative breast cancer
A new recommendation from NICE could revolutionise treatment for a rare form of triple-negative breast cancer.
Around 100 people per year with triple-negative breast cancer...
Breast cancer in men may cause infertility
Breast cancer in men is potentially associated with male infertility, a new study from The Institute of Cancer Research suggests.
The research team interviewed 1,998...
AI-powered breast cancer screening could soon be on the horizon
A Norwegian study suggests that Artificial Intelligence (AI) may be effectively used to perform breast cancer screening, potentially speeding up diagnostics for the disease.
The...
Exploring bariatric surgery to reduce obesity-associated breast cancer
New studies aim to explore the potential role of bariatric surgery in reducing the risk of breast cancer in people who classify as obese.
Bariatric...
Defence Therapeutics move closer to AccuTOXTM Phase I clinical trial
Defence Therapeutics has established an agreement with CATO SMS, who will advise on submitting the company’s clinical application to Health Canada to initiate a...
Live cells in human breast milk could aid breast cancer research
A new study focused on changes that take place during lactation by investigating cells found in human breast milk and how this could aid...
